BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 15939822)

  • 21. Endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy: a case report.
    Avella A; Pappalardo A; d'Amati G; Dello Russo A; Laurenzi F; Mancini M; Re F; Zachara E; Zecchi P; Tondo C
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):991-3. PubMed ID: 17403077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Peters S; Truemmel M; Koehler B
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
    Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S
    Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted endomyocardial biopsy using electroanatomical voltage mapping in the early stage of arrhythmogenic right ventricular cardiomyopathy.
    Ejima K; Shoda M; Manaka T; Hagiwara N
    Europace; 2009 Mar; 11(3):388-9. PubMed ID: 19168858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
    Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia.
    Haqqani HM; Kalman JM; Roberts-Thomson KC; Balasubramaniam RN; Rosso R; Snowdon RL; Sparks PB; Vohra JK; Morton JB
    J Am Coll Cardiol; 2009 Jul; 54(2):166-73. PubMed ID: 19573735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads.
    Furushima H; Chinushi M; Okamura K; Iijima K; Komura S; Tanabe Y; Okada S; Izumi D; Aizawa Y
    Europace; 2007 Oct; 9(10):951-6. PubMed ID: 17636305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations.
    Bauce B; Basso C; Rampazzo A; Beffagna G; Daliento L; Frigo G; Malacrida S; Settimo L; Danieli G; Thiene G; Nava A
    Eur Heart J; 2005 Aug; 26(16):1666-75. PubMed ID: 15941723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification.
    Zorzi A; Migliore F; Elmaghawry M; Silvano M; Marra MP; Niero A; Nguyen K; Rigato I; Bauce B; Basso C; Thiene G; Iliceto S; Corrado D
    J Cardiovasc Electrophysiol; 2013 Dec; 24(12):1321-7. PubMed ID: 24016194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current limitations and new perspectives in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia].
    Inama G; Pedrinazzi C; Gazzaniga P; Reduzzi C; Donato G; Munoz CV; Pacchioni A; Inama L; Della Frera W; Durin O
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):83S-89S. PubMed ID: 19195313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy.
    Corrado D; Buja G; Basso C; Thiene G
    J Electrocardiol; 2000; 33 Suppl():49-55. PubMed ID: 11265736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 12-Lead Electrocardiogram to Localize Region of Abnormal Electroanatomic Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Tschabrunn CM; Haqqani HM; Santangeli P; Zado ES; Marchlinski FE
    JACC Clin Electrophysiol; 2017 Jul; 3(7):654-665. PubMed ID: 29759533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging.
    Codreanu A; Odille F; Aliot E; Marie PY; Magnin-Poull I; Andronache M; Mandry D; Djaballah W; Régent D; Felblinger J; de Chillou C
    J Am Coll Cardiol; 2008 Sep; 52(10):839-42. PubMed ID: 18755347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia.
    Riley MP; Zado E; Bala R; Callans DJ; Cooper J; Dixit S; Garcia F; Gerstenfeld EP; Hutchinson MD; Lin D; Patel V; Verdino R; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):332-8. PubMed ID: 20558846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Peters S; Trümmel M; Koehler B; Westermann KU
    J Electrocardiol; 2007 Jan; 40(1):34-7. PubMed ID: 17118392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arrhythmogenic right ventricular cardiomyopathy (dysplasia): etiology, clinical presentation, diagnosis and treatment].
    Czarnowska E; Włodarska EK; Zaleska T
    Kardiol Pol; 2003 Jan; 58(1):58-63. PubMed ID: 14502306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.